4.7 Editorial Material

High-Dose Cisplatin for Head and Neck Cancer Lives On

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 36, Issue 11, Pages 1055-1057

Publisher

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2017.76.8614

Keywords

-

Categories

Funding

  1. Genentech
  2. Merck
  3. Amgen
  4. Regeneron Pharmaceuticals
  5. Bristol-Myers Squibb

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available